[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"patient-activation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:patient-activation":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,50,84,113],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":33,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":45,"leadSponsor":47,"locationsCount":4},"100600579","interactive-vs-standard-video-education-for-improving-outcomes-in-hemodialysis-patients-100600579",false,"NCT07099326","Interactive vs. Standard Video Education for Improving Outcomes in Hemodialysis Patients","Examining the Effects of Interactive Versus Conventional Video-Based Education on Activation, Treatment Adherence, and Weight Changes in Dialysis Patients: A Randomized Clinical Trial Protocol","Inclusion Criteria:\n\n1. Willingness to participate in the study;\n2. Literate (ability to read and write);\n3. Alertness and orientation to time, place, and person sufficient to respond to questions;\n4. No history of hearing or visual impairments;\n5. No cognitive disorders;\n6. Possession of a personal mobile phone or any other device capable of running interactive videos, and the ability to use it;\n7. No use of psychoactive medications;\n8. Confirmed diagnosis of chronic kidney disease by a nephrology specialist and having a medical record in the dialysis unit;\n9. Age between 18 and 65 years.\n\nExclusion Criteria:\n\n1. Withdrawal from the study at any stage;\n2. Failure to receive and watch the provided videos;\n3. Patient death;\n4. Transfer to a healthcare center outside the coverage of Shahid Beheshti University of Medical Sciences.","ALL","18 Years","65 Years",{"count":20,"type":21},165,"ESTIMATED","INTERVENTIONAL",[24],"NA","The goal of this clinical trial is to find out if educational videos-especially interactive ones-can help people on dialysis better manage their treatment.\n\nResearchers want to answer the following main questions:\n\nCan interactive or conventional video-based education help patients better understand and follow their treatment plan? Does this type of education improve patients' ability to control their weight changes between dialysis sessions? Does this type of education improve patients' activation? Is interactive video education more effective than regular (non-interactive) video education?\n\nWhat Will Happen in the Study:\n\nAdults on hemodialysis will take part in the study.\n\nThey will be randomly assigned to one of three groups:\n\nGroup A: Will receive 10 interactive educational video sessions (30 minutes each).\n\nGroup B: Will receive the same videos but in a non-interactive format. Group C (Control Group): Will receive routine education normally given at the dialysis center.\n\nVideos will be watched on a web platform. Interactive videos include pop-up questions and scenario-based feedback.\n\nAll participants will be followed up immediately, 1 month, and 3 months after the program ends.\n\nWhat Participants Will Do:\n\nWatch educational videos over several days (totaling 5 hours).\n\nAnswer questions and engage in follow-up group discussions.\n\nComplete surveys about their knowledge, treatment adherence, and health behaviors.\n\nGet weighed before and after dialysis sessions to monitor fluid retention.\n\nThis study aims to improve how dialysis patients manage their condition and to help healthcare providers design better educational tools.",[27,28,29,30,31,32],"Hemodialysis","Nurse","Educational Videos","Patient Activation","Weight Change","Treatment Adherence",[34,35,30,36,37,38],"Interactive Video-Based Education","Conventional Video-Based Education","Patient Treatment Adherence","Patients' Weight Changes","Dialysis","NOT_YET_RECRUITING","2025-07-31",{"date":42,"type":43},"2025-08-05","ACTUAL",{"date":42,"type":21},{"date":46,"type":21},"2025-10-05",{"name":48,"class":49},"Shahid Beheshti University of Medical Sciences","OTHER",{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":11,"sex":58,"minAge":17,"maxAge":4,"enrollmentInfo":59,"targetDuration":4,"studyType":22,"phases":61,"briefSummary":62,"conditions":63,"keywords":66,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":83},"100515282","at-home-breast-oncology-care-delivered-with-e-health-solutions-100515282","NCT05989477","At-home Breast Oncology Care Delivered With E-health Solutions","At-home Breast Oncology Care Delivered With E-health Solutions The ABODE Study","ABODE","Inclusion Criteria:\n\n* Females (assigned female at birth)\\*\n* Diagnosed with first, primary invasive BC\n* Must have surgery as their first step in treatment pathway\n* Age≥18\n* Access to an electronic device with connection to the internet\n* A valid email address\n* Can communicate in English \\*Since BC risk is sex-related and based on physiological values, our inclusion criteria are based on sex (not gender)\n\nExclusion criteria:\n\n* Males (assigned male at birth), as BC surgical treatment options and experiences are different\n* Diagnosed with non-operable breast cancer\n* Stage 4\u002Fmetastatic (whether determined at diagnosis or during surgery)\n* Those with hearing or visual challenges\n* Neo-adjuvant chemotherapy\n* Should not be enrolled in any other UHN study using an e-Health application\n* Breast cancer surgery is scheduled for less 5 business days after enrollment","FEMALE",{"count":60,"type":21},200,[24],"The COVID-19 pandemic has significantly impacted healthcare service delivery, highlighting the need for high quality virtual patient care. Our team has developed a multi-dimensional remote eHealth solution for newly diagnosed breast cancer patients and their practitioners to use during the diagnostic and follow-up period. The ABODE study involved development of a Breast Cancer Treatment Application (app) which will facilitate virtual consultations, deliver patient education material, and collect patient reported outcome measures (PROMs). Using a randomized controlled trial design, the team will evaluate a variety of outcomes for breast cancer patients who will use the app throughout their diagnosis and treatment period.\n\nPrimary Objective: To compare changes in patient activation (assessed by PAM-13) over 1 year among newly diagnosed breast cancer patients between those using the app and those receiving standard care.\n\nSecondary Objectives:\n\n1. Compare additional PROMs between the standard care and intervention groups\n2. Describe health service outcomes among app users\n3. Explore end-user experience of using the app\n4. Measure activity levels using wearable devices",[64,30,65],"Patient Engagement","Patient Reported Outcome Measures",[67,68,69,70,71,72],"e-Health","m-Health","Mobile Application","Psychosocial Oncology","Survivorship","Breast Cancer","RECRUITING","2025-04-11",{"date":76,"type":43},"2025-04-16",{"date":78,"type":43},"2023-06-22",{"date":80,"type":21},"2026-06-22",{"name":82,"class":49},"University Health Network, Toronto",1,{"id":85,"slug":86,"hasResults":11,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":90,"eligibilityCriteria":91,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":92,"targetDuration":4,"studyType":22,"phases":94,"briefSummary":95,"conditions":96,"keywords":103,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":83},"100508571","electronic-patient-decision-support-system-for-patients-with-type-2-diabetes-diapadess-100508571","NCT05902156","Electronic Patient Decision Support System for Patients with Type 2 Diabetes (DiaPaDeSS)","The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters","DiaPaDeSS","Inclusion Criteria:\n\n* Patients with type 2 diabetes who had been followed up and treated at the Endocrinology and Metabolic Diseases Polyclinic\n* Aged between 18-65 years\n* Patients who know their diagnosis and can verbally express it\n* Have been diagnosed with type 2 diabetes for at least six months\n* Who are literate\n* Who have internet access at home, who have one of the tools such as a computer, tablet or smartphone and can use these tools\n* Consented to participate in the study\n* Had no other psychiatric or mental barriers to answering the questions, language or cognitive difficulties, and barriers to verbal or written communication\n\nExclusion Criteria:\n\n* Diagnosed with myocardial infarction, stroke or diabetic foot in the last six months\n* Diagnosed with type 1 diabetes or gestational diabetes\n* Diagnosed with terminal illness\n* Using steroid therapy\n* Had pregnant\n* Having dementia and cognitive deficits\n* Having retinopathy or advanced neuropathy\n* Patients whose information is not allowed to be accessed",{"count":93,"type":21},72,[24],"This study evaluates the effects of an electronic patient decision support system developed for the use of patients with type 2 diabetes (DiaPaDeSS) on self-management, patient activation, and metabolic parameters. To manage type 2 diabetes after discharge, patients must continue to perform interventions at home, such as blood glucose monitoring, blood pressure measurement, weight measurement, medication use, and foot care. To achieve this, patient's self-management and activation levels should be increased. This can also lead to positive improvements in the metabolic parameters. It would be beneficial to develop DiaPaDeSS that can increase the self-management and activation levels of patients with type 2 diabetes. The investigators will develop the DiaPaDeSS intervention protocol. Our content includes patient education information about type 2 diabetes, self-management practice tasks (daily, weekly, quarterly), a type 2 diabetes patient education program according to DiaPaDeSS algorithms, and measurement questionnaires. The content of the DiaPaDeSS will be evaluated by 10 experts in the fields of medicine, nursing, and informatics. A feasibility test with seven patients will be conducted to evaluate the usability of DiaPaDeSS. A single-blind, randomized controlled trial design will be used. Patients with type 2 diabetes will be pretested and randomized (intervention 36, control 36) to the DiaPaDeSS intervention and control groups. Both the DiaPaDeSS intervention and control groups will use the DiaPaDeSS for three months. While participants in the DiaPaDeSS intervention group can reach all contents of the DiaPaDeSS, others can reach only these fields: self-management practice tasks (daily, weekly, quarterly), and measurements questionnaires. The effectiveness of the DiaPaDeSS will be evaluated at baseline and at month 3.",[97,98,30,99,100,101,102],"Mobile Health","Type 2 Diabetes","Self-Management","Decision Support System","Nursing","Randomized Controlled Trial",[97,98,30,100,99,101,102],"2025-02-04",{"date":106,"type":43},"2025-02-06",{"date":108,"type":21},"2025-03-30",{"date":110,"type":21},"2025-11-01",{"name":112,"class":49},"Akdeniz University",{"id":114,"slug":115,"hasResults":11,"nctId":116,"briefTitle":117,"officialTitle":118,"acronym":4,"eligibilityCriteria":119,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":120,"enrollmentInfo":121,"targetDuration":4,"studyType":22,"phases":123,"briefSummary":124,"conditions":125,"keywords":4,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":127,"lastUpdatePostDateStruct":128,"startDateStruct":130,"completionDateStruct":132,"leadSponsor":134,"locationsCount":83},"100508458","developing-and-testing-mobile-health-question-prompt-list-in-gastroesophageal-reflux-disease-100508458","NCT05900687","Developing and Testing Mobile Health Question Prompt List in Gastroesophageal Reflux Disease","Developing, Refining, and Testing a Mobile Health Question Prompt List in Gastroesophageal Reflux Disease","Inclusion Criteria:\n\n* clinical diagnosis of GERD\n* GerdQ score of \\>=8\n* documented PPI use for GERD\n* internet access at home or computer\u002Fmobile device\n* ability to provide written or e-consent.\n\nExclusion Criteria:\n\n* Established diagnosis that mimic GERD symptoms (e.g. achalasia by prior esophageal manometry)\n* non-English speaking patients","100 Years",{"count":122,"type":21},150,[24],"More than 40% of patients with gastroesophageal reflux disease (GERD) experience uncontrolled, chronic symptoms. This proposal aims to improve symptom control for patients with GERD, by developing a mobile health (mHealth) Question Prompt List (QPL) intervention that helps patient ask questions with his\u002Fher physician about GERD. The first aim is to gather feedback about daily challenges of living with GERD. The second aim is to gather feedback on the prototype app. The third (primary) aim of this project is to develop the mHealth application and measure differences in patient activation when used compared to standard of care.",[126,30],"Gastroesophageal Reflux","2023-05-31",{"date":129,"type":43},"2023-06-12",{"date":131,"type":21},"2023-07-01",{"date":133,"type":21},"2028-06-01",{"name":135,"class":49},"Stanford University"]